Announcement

Collapse
No announcement yet.

Euro Surveill. Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Euro Surveill. Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study

    [Source: Eurosurveillance, full page: (LINK). Abstract, edited.]


    Eurosurveillance, Volume 19, Issue 9, 06 March 2014 / Rapid communications

    Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study

    S Jiménez-Jorge <SUP>1</SUP><SUP>,2</SUP>, F Pozo<SUP>3</SUP>, S de Mateo<SUP>1</SUP><SUP>,2</SUP>, C Delgado-Sanz<SUP>1</SUP><SUP>,2</SUP>, I Casas<SUP>3</SUP>, M García-Cenoz<SUP>2</SUP><SUP>,4</SUP>, J Castilla<SUP>2</SUP><SUP>,4</SUP>, R Sancho<SUP>2</SUP><SUP>,5</SUP>, L Etxebarriarteun-Aranzabal<SUP>6</SUP>, C Quinones<SUP>7</SUP>, E Martínez<SUP>7</SUP>, T Vega<SUP>8</SUP>, A Garcia<SUP>8</SUP>, J Giménez<SUP>9</SUP>, J M Vanrell<SUP>9</SUP>, D Castrillejo<SUP>10</SUP>, A Larrauri<SUP>1</SUP><SUP>,2</SUP>, on behalf of the Spanish Influenza Sentinel Surveillance System (SISS)<SUP>11</SUP>
    <SUP></SUP>
    <SUP>1</SUP>National Centre of Epidemiology, Institute of Health Carlos III, Madrid, Spain - 2 CIBER Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain - 3 National Centre for Microbiology, National Influenza Reference Laboratory, WHO National Influenza Centre, Institute of Health Carlos III, Madrid, Spain - 4 Instituto de Salud Pública de Navarra, Pamplona, Spain - 5 Dirección de Salud Pública y Adicciones de Gipuzkoa, País Vasco, Spain - 6 Subdirección de Salud Pública y Adicciones de Araba/Álava, País Vasco, Spain - 7 Servicio de Epidemiología y Prevención Sanitaria, Dirección General de Salud Pública y Consumo de La Rioja, La Rioja, Spain - 8 Dirección General de Salud Pública, Consejería de Sanidad de Castilla y León, Castilla y León, Spain - 9 Servicio de Epidemiología, Dirección General de Salut Pública, Baleares, Spain - 10 Servicio de Epidemiología, Dirección General de Sanidad y Consumo, Consejería de Bienestar Social y Sanidad, Ciudad Autónoma de Melilla, Melilla, Spain - 11 The members are listed at the end of the article
    ______

    Citation style for this article: Jiménez-Jorge S, Pozo F, de Mateo S, Delgado-Sanz C, Casas I, García-Cenoz M, Castilla J, Sancho R, Etxebarriarteun-Aranzabal L, Quinones C, Martínez E, Vega T, Garcia A, Giménez J, Vanrell JM, Castrillejo D, Larrauri A, on behalf of the Spanish Influenza Sentinel Surveillance System (SISS). Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study. Euro Surveill. 2014;19(9):pii=20727. Available online: http://www.eurosurveillance.org/View...rticleId=20727
    Date of submission: 14 February 2014

    ______

    Adjusted early estimates of the 2013/14 influenza vaccine effectiveness (VE) in Spain for all age groups was 35% (95% CI: −9 to 62), 33% (95% CI: −33 to 67) and 28% (95% CI: −33 to 61) against any influenza virus type, A(H1N1)pdm09 and A(H3N2) viruses, respectively. For the population targeted for vaccination, the adjusted VE was 44% (95% CI: −11 to 72), 36% (95% CI: −64 to 75) and 42% (95% CI: −29 to 74), respectively. These preliminary results in Spain suggest a suboptimal protective effect of the vaccine against circulating influenza viruses.


    -
    --------

  • #2
    Re: Euro Surveill. Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study

    From the above text conclusions:

    (...)

    The suboptimal protective effect of the vaccine should also lead to a clear public health message underlying the importance of early antiviral treatment for patients at high risk of influenza complications, and the adoption of non-pharmacological preventive measures to avoid influenza infection.


    (...)


    -
    -----

    Comment

    Working...
    X